Drug Price Trends for NDC 00378-2330

Average Pharmacy Cost for 00378-2330

Drug Name	NDC	Price/Unit ($)	Unit	Date
RUFINAMIDE 200 MG TABLET	00378-2330-78	1.49943	EACH	2025-04-23
RUFINAMIDE 200 MG TABLET	00378-2330-78	1.68630	EACH	2025-03-19
RUFINAMIDE 200 MG TABLET	00378-2330-78	1.82766	EACH	2025-02-19
RUFINAMIDE 200 MG TABLET	00378-2330-78	1.76602	EACH	2025-01-22

Best Wholesale Price for NDC 00378-2330

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for Drug NDC: 00378-2330

Understanding the NDC Code

To begin analyzing the market and price projections for a drug identified by the National Drug Code (NDC) 00378-2330, it is crucial to understand what the NDC code represents.

• NDC Structure: The NDC is a 10-digit, three-segment number. The first segment is the labeler code, assigned by the FDA, which identifies the firm that manufactures or distributes the drug. The second segment is the product code, assigned by the firm, which identifies the specific strength, dosage form, and formulation of the drug. The third segment is the package code, also assigned by the firm, which identifies the package sizes and types[1][4].

Identifying the Drug

• Labeler Code: The first segment of the NDC 00378-2330 is "00378," which is the labeler code.
• Product Code: The second segment is "2330," indicating the specific product.
• Package Code: The third segment is not provided in the query, but it would specify the package size and type.

Market Context

To analyze the market and price projections, we need to consider several factors:

Drug Category and Usage

• If the drug falls under a category like specialty pharmaceuticals, it is likely to be subject to higher price increases. For instance, specialty pharmaceuticals, which include drugs for complex or chronic conditions, are driving a projected 3.8% increase in drug prices in 2024[2].

Regulatory Environment

• The FDA's Drug Listing Act and regulatory provisions require firms to submit detailed information about their drug products, including pricing. This information is crucial for understanding the drug's market position and potential price changes[1].

Price Trends

• Recent data shows that prescription drug prices have been increasing significantly. From January 2022 to January 2023, the average price increase was 15.2%, with some drugs experiencing much higher increases[5].

Price Projections

General Trends

• The overall trend in the pharmaceutical market indicates rising prices, particularly for specialty and high-cost drugs. Vizient projects a 3.8% increase in drug prices, driven largely by specialty pharmaceuticals[2].

Specific Drug Analysis

• Without the exact name and category of the drug (which can be found using the NDC Directory), it's challenging to provide precise price projections. However, if the drug is a specialty pharmaceutical or treats a high-cost, complex condition, it is likely to follow the trend of increasing prices.

Example: Specialty Pharmaceuticals

• For drugs like those used in the treatment of non-small cell lung cancer (NSCLC), the market is expected to grow significantly due to the incorporation of premium-priced immunotherapies and targeted therapies. Drugs like Tagrisso, Keytruda, and Opdivo are projected to achieve blockbuster status with substantial sales growth by 2025[3].

Impact of Regulatory and Market Factors

FDA Listings and Compliance

• The drug's inclusion in the NDC Directory and compliance with FDA regulations are critical. Non-compliance can result in the drug not being listed, which could impact its market presence and pricing[1].

Generic and Patent Expirations

• The expiration of patents for blockbuster drugs can lead to the introduction of generics, which can significantly reduce prices. For example, the patent expiration of Tarceva and Alimta has led to a decline in their sales and an increase in generic sales[3].

Key Takeaways

• NDC Code Significance: Understanding the NDC code structure is essential for identifying the drug and its market context.
• Market Trends: Specialty pharmaceuticals and high-cost drugs are driving price increases in the pharmaceutical market.
• Regulatory Compliance: Compliance with FDA regulations is crucial for a drug's market presence and pricing.
• Generic Competition: Patent expirations and the introduction of generics can significantly impact drug prices.

FAQs

Q: What does the NDC code represent?

• The NDC code is a unique 10-digit number that identifies a drug product, including the labeler, product, and package size.

Q: How do I find the specific drug associated with the NDC 00378-2330?

• You can use the FDA's NDC Directory to search for the drug using the NDC number.

Q: What are the main drivers of drug price increases in 2024?

• Specialty pharmaceuticals, including weight loss drugs and gene therapies, are driving the projected 3.8% increase in drug prices in 2024.

Q: How do patent expirations affect drug prices?

• Patent expirations lead to the introduction of generic drugs, which can significantly reduce prices and impact the sales of the original branded drugs.

Q: Where can I find detailed information about drug price changes?

• The ASPE issue brief on changes in the list prices of prescription drugs provides comprehensive data on drug price changes over several years[5].

Sources

1. FDA: National Drug Code Database Background Information
2. Vizient Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
3. Drug Development: NSCLC Market - Global Drug Forecast & Market Analysis to 2025
4. YouTube: NDC Directory (March 2015)
5. ASPE: Changes in the List Prices of Prescription Drugs, 2017-2023